Showing 221 - 240 results of 56,499 for search '(( 20 a decrease ) OR ( 5 ((((step decrease) OR (mean decrease))) OR (we decrease)) ))', query time: 0.91s Refine Results
  1. 221
  2. 222
  3. 223

    Table_1_Dimethyl Sulfoxide Decreases Levels of Oxylipin Diols in Mouse Liver.xlsx by Poonamjot Deol (773907)

    Published 2019
    “…In contrast, DMSO had no effect on the epoxide precursors or other oxylipins including those derived from arachidonic acid (C20:4n6) or eicosapentaenoic acid (EPA, C20:5n3). …”
  4. 224
  5. 225
  6. 226
  7. 227
  8. 228

    DataSheet2_Treatment of wild-type mice with 2,3-butanediol, a urinary biomarker of Fmo5−/− mice, decreases plasma cholesterol and epididymal fat deposition.pdf by Sunil Veeravalli (5074115)

    Published 2022
    “…<p>We previously showed that Fmo5<sup>−/−</sup> mice exhibit a lean phenotype and slower metabolic ageing. …”
  9. 229

    DataSheet1_Treatment of wild-type mice with 2,3-butanediol, a urinary biomarker of Fmo5−/− mice, decreases plasma cholesterol and epididymal fat deposition.PDF by Sunil Veeravalli (5074115)

    Published 2022
    “…<p>We previously showed that Fmo5<sup>−/−</sup> mice exhibit a lean phenotype and slower metabolic ageing. …”
  10. 230
  11. 231
  12. 232
  13. 233
  14. 234
  15. 235

    S5 Data - by Ayuta Kishimoto (16814662)

    Published 2023
    “…On the other hand, the IC analysis showed a gradual decrease in chlorite ions in the acidic sodium chlorite solution. …”
  16. 236
  17. 237

    Simultaneously inhibition <i>Nlu-miR-34</i> and <i>NlInR2</i> in SW strain induced the decrease of SW BPHs. by Xinhai Ye (6857771)

    Published 2019
    “…<p>(A) Antagomir-34 (with two different quantities) and ds<i>NlInR2</i> (0.84 ng) were injected into the third instar SW strain nymphs, showed that injection of antagomir-34 decreased the ratio of SW type BPH (Chi-square test, 40ng: χ<sup>2</sup> = 5.8, df = 1, <i>p</i> = 0.003; 60ng: χ<sup>2</sup> = 7.9, df = 1, <i>p</i> = 0.042). …”
  18. 238

    Supplementary Material for: SGLT2 inhibitors decrease overhydration and proteasuria in patients with chronic kidney disease: a longitudinal observational study by Schork A. (17795387)

    Published 2024
    “…Results: 42 patients (29 % with diabetic/hypertensive CKD, 31 % with IgA nephropathy; 88 % dapagliflozin 10 mg, 10 % dapagliflozin 5 mg, 2 % empagliflozin 20 mg; median eGFR 46 mL/min/1.73m² and albuminuria 1911 mg/g creatinine) participated in the study. …”
  19. 239

    Supplementary Material for: SGLT2 inhibitors decrease overhydration and proteasuria in patients with chronic kidney disease: a longitudinal observational study by Schork A. (17795387)

    Published 2024
    “…Results: 42 patients (29 % with diabetic/hypertensive CKD, 31 % with IgA nephropathy; 88 % dapagliflozin 10 mg, 10 % dapagliflozin 5 mg, 2 % empagliflozin 20 mg; median eGFR 46 mL/min/1.73m² and albuminuria 1911 mg/g creatinine) participated in the study. …”
  20. 240